Product Information: Name: Alluvi BPC-157 & TB-500 Concentration: 40 mg Form: Lyophilized powder Use: R&D Only Origin: UK Packaging: Sealed sterile vial Storage: Store in a cool, dry environment Weight Loss & Metabolic Research Interest Recent studies and ongoing research have shown increasing scientific interest in BPC-157 and TB-500 for their potential roles in: Inflammation and tissue response research Metabolic regulation and weight study models Cell regeneration and healing Performance recovery research Disclaimer: Alluvi is not intended for human use
Learn More Microdosing Tirzepatide A gentle, lower-dose approach that may support moderate weight loss, help push past plateaus, and quiet food noise, with clinician guidance every step of the way
glutathione is a potential supplement to overall wellness, not a weight-loss amplifier
Patients with slower ALS progression tend to have higher levels of circulating Tregs, whereas rapidly progressing patients have fewer or dysfunctional Tregs (112)
Tirzepatide was engineered by modifying the native GIP peptide sequence with a fatty acid chain that extends its half-life to approximately five days, making once-weekly dosing possible
